| R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II … AS Pappo, SR Patel, J Crowley, DK Reinke, KP Kuenkele, SP Chawla, ... Journal of Clinical Oncology 29 (34), 4541-4547, 2011 | 368 | 2011 |
| Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. GC Toner, DM Panicek, RT Heelan, NL Geller, SY Lin, D Bajorin, ... Journal of clinical oncology 8 (10), 1683-1694, 1990 | 331 | 1990 |
| Filgrastim in patients with chemotherapy-induced febrile neutropenia: a double-blind, placebo-controlled trial DW Maher, GJ Lieschke, M Green, J Bishop, R Stuart-Harris, M Wolf, ... Annals of Internal medicine 121 (7), 492-501, 1994 | 316 | 1994 |
| ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ... Annals of oncology 29 (8), 1658-1686, 2018 | 310 | 2018 |
| Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel JD Shapiro, MJ Millward, D Rischin, M Michael, V Walcher, PA Francis, ... Gynecologic oncology 63 (1), 89-93, 1996 | 296 | 1996 |
| Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from … EW Steyerberg, HJ Keizer, SD Fosså, DT Sleijfer, GC Toner, ... Journal of clinical oncology 13 (5), 1177-1187, 1995 | 295 | 1995 |
| Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer JF Bishop, J Dewar, GC Toner, J Smith, MHN Tattersall, IN Olver, ... Journal of Clinical Oncology 17 (8), 2355-2355, 1999 | 265 | 1999 |
| A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of … D Ball, J Bishop, J Smith, P O'Brien, S Davis, G Ryan, I Olver, G Toner, ... Radiotherapy and Oncology 52 (2), 129-136, 1999 | 191 | 1999 |
| Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors GC Toner, NL Geller, C Tan, J Nisselbaum, GJ Bosl Cancer research 50 (18), 5904-5910, 1990 | 180 | 1990 |
| Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours AO Altuntas, J Slavin, PJ Smith, SM Schlict, GJ Powell, S Ngan, G Toner, ... ANZ journal of surgery 75 (4), 187-191, 2005 | 168 | 2005 |
| A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer J Crown, A Jakubowski, N Kemeny, M Gordon, C Gasparetto, G Wong, ... | 159 | 1991 |
| Active surveillance is the preferred approach to clinical stage I testicular cancer CR Nichols, B Roth, P Albers, LH Einhorn, R Foster, S Daneshmand, ... Journal of Clinical Oncology 31 (28), 3490-3493, 2013 | 146 | 2013 |
| Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial GC Toner, MR Stockler, MJ Boyer, M Jones, DB Thomson, VJ Harvey, ... The Lancet 357 (9258), 739-745, 2001 | 133 | 2001 |
| Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer. J Zalcberg, M Millward, J Bishop, M McKeage, A Zimet, G Toner, ... Journal of clinical oncology 16 (5), 1948-1953, 1998 | 127 | 1998 |
| Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features GC Toner, NL Geller, SY Lin, GJ Bosl Cancer 67 (8), 2049-2057, 1991 | 116 | 1991 |
| Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer. MJ Millward, J Zalcberg, JF Bishop, LK Webster, A Zimet, D Rischin, ... Journal of clinical oncology 15 (2), 750-758, 1997 | 105 | 1997 |
| Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humans KG Moss, GC Toner, JM Cherrington, DB Mendel, AD Laird Journal of Pharmacology and Experimental Therapeutics 307 (2), 476-480, 2003 | 99 | 2003 |
| A randomised crossover trial of chemotherapy in the home: patient preferences and cost anaiysis D Rischin, MA White, JP Matthews, GC Toner, K Watty, AJ Sulkowski, ... Medical journal of Australia 173 (3), 125-127, 2000 | 99 | 2000 |
| Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. MJ Millward, JF Bishop, M Friedlander, JA Levi, D Goldstein, IN Olver, ... Journal of clinical oncology 14 (1), 142-148, 1996 | 94 | 1996 |
| The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross‐sectional study AB Smith, M King, P Butow, T Luckett, P Grimison, GC Toner, M Stockler, ... Psycho‐oncology 22 (11), 2557-2564, 2013 | 93 | 2013 |
Danny RischinPeter MacCallum Cancer Centre在 petermac.org 的电子邮件经过验证
